Osaic Holdings
THRX

Osaic Holdings’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Osaic Holdings’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,043
Closed -$24.5K – 7507
2023
Q4 		$24.5K Buy
6,043
+3,250
+116% +$9.92K ﹤0.01% 5382
2023
Q3 		$7.51K Hold
2,793
– – ﹤0.01% 6087
2023
Q2 		$26.1K Hold
2,793
– – ﹤0.01% 5393
2023
Q1 		$24.8K Buy
+2,793
New +$27.4K ﹤0.01% 5442

Osaic Holdings's THRX Position: Q1 2024 in Review

Osaic Holdings sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 6,043 shares — an estimated $24.5K sold.

Osaic Holdings first reported a position in THRX in Q1 2023 and held it in 4 quarters. The position peaked at $26.1K in Q2 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • Osaic Holdings reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 6,043 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $24.5K.
  • Osaic Holdings first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • Osaic Holdings's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $26.1K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.